Side-by-side comparison of AI visibility scores, market position, and capabilities
Medical device company projecting CT/MRI anatomy directly onto patients during surgery for real-time guidance; YC-backed $500K raised at $750K-$900K revenue with SIGGRAPH 2025 research presentation.
Illuminant Surgical is a medical device company developing Skylight — a real-time anatomical projection system that displays medical imaging data (CT scans, MRI, ultrasound) directly onto the patient's body surface during surgery, giving surgeons continuous visual guidance about subsurface anatomy without looking away from the operative field. Founded in 2022 and backed by Y Combinator with $500,000+ raised from YC, the US National Science Foundation, and angel investors, Illuminant generated $750,000-$900,000 in revenue in 2024 with an 18-person team and presented Skylight research at SIGGRAPH 2025.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.